Intratumoral IFNα-2b has been investigated for the treatment of basal cell carcinomas and has been shown to be an alternative, effective, and cosmetically elegant treatment for basal cell carcinoma [26]. This evidence concerns the gene IFNA2 and basal cell carcinoma.